-
Universal barcodes unlock fast-paced small molecule synthesis
12/11/2024
Learn how St. Jude scientists discovered a universal barcode in fragmentation patterns to revolutionize chemical reaction analysis and small molecule synthesis.
-
TelevisaUnivision Brings Together Latin Media and Artists for Annual Promesa y Esperanza® Fundraiser Supporting St. Jude Children’s Research Hospital
12/10/2024
TelevisaUnivision brings together Latin media and artists for annual Promesa y Esperanza fundraiser supporting St. Jude Children’s Research Hospital, raising $5.3 million.
-
St. Jude names Maria Megdal as executive vice president and chief administrative officer
12/10/2024
Medgal will oversee departments vital to St. Jude operations. She previously led operations at major cancer centers in Boston and New York
-
ALSAC announces transition of Richard C. Shadyac, Jr. as CEO
12/09/2024
Richard C. Shadyac Jr. will step down as President and Chief Executive Officer of ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital, on March 1, 2025.
-
Twenty-three years running for the kids of St. Jude: St. Jude Memphis Marathon Weekend reaches fundraising record
12/07/2024
The 2024 St. Jude Memphis Marathon Weekend®, presented by Juice Plus+® marked another major success in the event’s 23-year history, raising about $16 million for St. Jude Children’s Research Hospital.
-
Mint Mobile donates $250,000 to benefit St. Jude Children's Research Hospital
12/06/2024
This GivingTuesday and alongside Ryan Reynolds, Mint Mobile announced that it is donating earnings from new customer purchases that took place on GivingTuesday (Dec. 3) to St. Jude — for a total contribution of $250,000.
-
Research links a genetic risk for schizophrenia to a malformed skull
12/05/2024
See how St. Jude scientists study 22q schizophrenia disorder finding flocculus and paraflocculus growth in cerebellum curbed by lack of skull growth gene Tbx1
-
Predicting cardiac issues in cancer survivors using a serum protein panel test
12/03/2024
See how a blood serum panel of 27 proteins can accurately predict anthracycline-related cardiomyopathy risk in subclinical pediatric cancer survivors
-
Nicole Kidman, Keith Urban, Heidi Klum, Meghan Trainor, Shawn Johnson, brands and influencers unite this GivingTuesday for St. Jude Children’s Research Hospital
11/26/2024
This GivingTuesday, Dec. 3, celebrities, influencers and leading brands are calling on communities nationwide to “Join Our St. Jude Family” by supporting St. Jude in its efforts to research and treat childhood cancer and other life-threatening diseases.
-
St. Jude appoints leading scientist to create groundbreaking Center of Excellence for Structural Cell Biology
11/21/2024
Georgios Skiniotis, PhD, to develop and lead new center focusing on advanced imaging techniques, including cryo-ET.
-
Scientists from St. Jude Children’s Research Hospital listed among most cited globally
11/19/2024
Meet the St. Jude scientists named to the 2024 list of Highly Cited Researchers produced by Clarivate, to celebrate the global influence of their discoveries.
-
St. Jude researchers identify unexpected genetic link between skin disorder and inner ear
11/18/2024
Discover St. Jude research showing how the ABC transporter links inner ear development with hearing impairment in dyschromatosis universalis hereditaria.
-
Glutamine metabolic switch is key to red blood cell development and disease
11/14/2024
See how a switch from glutamine catabolism to glutamine production is a vital step in blood cell development linking the process to sickle cell disease and β-thalassemia
-
Tumor suppressor forms gel-like assemblies to sacrifice cancer cells
11/11/2024
See how the tumor suppressor p14ARF undergoes phase separation with nucleophosmin to form condensates which arrest ribosome formation to kill cancer cells.
-
ALSAC appoints new Chief Marketing and Brand, Data and Analytics officers to drive fundraising growth for St. Jude Children's Research Hospital
11/04/2024
Samantha Maltin and Ankur Jain are joining the executive leadership team of ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital, as Chief Marketing and Brand, Data and Analytics officers.
-
Mitchell Weiss of St. Jude Children’s Research Hospital elected to the National Academy of Medicine
10/23/2024
Leading expert in catastrophic blood disorders becomes the seventh St. Jude faculty member tapped for this honor
-
Nutrients and organelle signaling shape tissue immunity
10/14/2024
Discover research by Hongbo Chi, PhD, that uncovers the interplay between organelles, nutrient-dependent signaling pathways and tissue immunity.
-
Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy
10/10/2024
Explore how disruptions in ASXL1 were correlated with better patient responses to immune checkpoint inhibition and long-term tumor control in model systems.
-
St. Jude ranks in top 10 of U.S. News Best Children's Hospitals for Cancer
10/08/2024
US News & World Report has recognized St. Jude Children's Research Hospital as one of the top 10 pediatric cancer hospitals for the 17th straight year.
-
Hannah Storm, ESPN Anchor, award-winning director, producer to receive prestigious Pat Summerall Award during Super Bowl LIX
10/07/2024
Hannah Storm, ESPN Anchor, award-winning director, producer to receive prestigious Pat Summerall Award during Super Bowl LIX
-
St. Jude names M. Madan Babu, PhD, senior vice president and chief data scientist
10/01/2024
M. Madan Babu, PhD, will lead new $195 million data science enterprise for biologic discovery to advance pediatric medicine.
-
Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows its promise for gene editing
10/01/2024
See how structures of Fanzor2, a relation of the transposon family TnpB, show how the protein can be used in genome engineering technology like CRISPR-Cas9.
-
St. Jude Spirit of the Dream honors three changemakers for community impact
09/24/2024
Carolyn Chism Hardy, Peter Woods and A C Wharton, Jr. celebrated for service to families of St. Jude Children’s Research Hospital.
-
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes
09/24/2024
Learn about St. Jude clinical trial findings from Hiroto Inaba, MD, PhD, showing that genomics can guide risk assessment and leukemia treatment intensity.
-
Sigma Gamma Rho Sorority, Inc. announces new $2 million commitment for St. Jude Children's Research Hospital
09/12/2024
Sigma Gamma Rho Sorority, Inc., a member of the National Pan-Hellenic Council (NPHC) known informally as the Divine Nine, has unveiled a historic pledge to raise $2 million for St. Jude Children’s Research Hospital® by 2028.
-
Urate transporter structures reveal the mechanism behind important drug target for gout
09/09/2024
Discover how cryo-EM insights into URAT1, a urate transporter and member of the SLC22 transporter family advance gout and hypouricemia drug discovery
-
Communities across America unite to support St. Jude Children's Research Hospital for Childhood Cancer Awareness Month
08/29/2024
This September, communities across the nation will come together for Childhood Cancer Awareness Month by supporting St. Jude Children's Research Hospital® as it continues driving research and treatment for pediatric cancer and other life-threatening diseases.
-
Acquisition in Memphis' Pinch District enables future St. Jude growth
08/28/2024
In a letter from ALSAC President and CEO Rick Shadyac, St. Jude announces the acquisition of 23 parcels of land in the Pinch District, expanding the existing St. Jude campus westward.
-
Early interventions may improve long-term academic achievement in young childhood brain tumor survivors
08/21/2024
Find how children who survive a brain tumor often fall behind peers in academic readiness, but access to early developmental resources may reduce the gap.
-
T helper cells may be the key to improving annual influenza vaccines
08/20/2024
Explore how T follicular helper cells indirectly control the anti-influenza immune response, which could lead to improvements in annual flu vaccine design.
-
St. Jude mourns loss of beloved member of St. Jude family, Phil Donahue
08/19/2024
St. Jude laments the passing of television icon Phil Donahue. Donahue was married to Emmy Award-winning actress, author and St. Jude National Outreach Director Marlo Thomas, the eldest daughter of St. Jude founder Danny Thomas.
-
Danny Thomas Celebrity-Am, stars drive home importance of supporting St. Jude Children’s Research Hospital
08/16/2024
Danny Thomas Celebrity-Am, stars drive home importance of supporting St. Jude Children’s Research Hospital
-
First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition
08/14/2024
Explore the first successful treatment of a pediatric patient with high-risk refractory neuroblastoma using PARP inhibition guided by clinical genomics.
-
FedEx and St. Jude Children’s Research Hospital celebrate a dozen years of Purple Eagle honorees
08/14/2024
A seven-year-old who was diagnosed with acute lymphoblastic leukemia after he started kindergarten in the fall of 2022, Micah was honored Wednesday ahead of the first day of competition at the FedEx St. Jude Championship at TPC Southwind.
-
New research from Children’s Hospital of Philadelphia and St. Jude poised to transform approach to diagnosing and treating acute leukemia in children
08/14/2024
Explore How research St. Jude and CHOP is transforming Acute Leukemia Diagnosis and Treatment in Children.
-
PGA TOUR pro Jordan Spieth and family visit St. Jude Children’s Research Hospital, presents $500,000 Jordan Spieth Family Foundation grant
08/13/2024
PGA TOUR star Jordan Spieth and his wife, Annie, kicked off FedEx St. Jude Championship week with a special visit: a personal tour of St. Jude where they presented a check for $500,000 on behalf of the Jordan Spieth Family Foundation.
-
St. Jude Children’s Research Hospital, FedEx and PGA TOUR team up to help make cures possible for childhood cancer
08/12/2024
Seventy of the world’s top PGA TOUR golfers will tee off in Memphis on August 15 for the 2024 FedEx St. Jude Championship, an event that has raised $74 million to benefit the lifesaving mission of St. Jude Children’s Research Hospital® since 1970.
-
Study reveals oleoyl-ACP-hydrolase underpins lethal respiratory viral disease
08/12/2024
Learn how research from St. Jude, Doherty Institute and others revealed that OLAH underpins deadly respiratory disease from viruses such as RSV and Sars-Cov-2.
-
Scientists identify genes linked to relapse in the most common form of childhood leukemia
08/09/2024
Discover St. Jude research from Charles Mullighan, MD, identifying novel genetic alterations linked to relapse in standard risk acute lymphoblastic leukemia.
-
St. Jude identifies SARS-CoV-2 “mimic” contributing to pediatric inflammatory syndrome
08/07/2024
Discover St. Jude research from Paul Thomas, PhD, linking SARS-CoV-2 infections and molecular mimicry with multisystem inflammatory syndrome in children.
-
Genetic ‘episignatures’ guide researchers in identifying causes of unsolved epileptic neurological disorders
08/06/2024
See how DNA methylation patterns can be used to identify and diagnose rare neurogenetic disorder cases of developmental and epileptic encephalopathies
-
Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia
08/05/2024
Explore how scientists at St. Jude Children’s Research Hospital have identified causes for age-related differences in the treatment outcomes of B-cell acute lymphoblastic leukemia.
-
Improved chemokine homing enhances CAR T-cell therapy for osteosarcoma
08/05/2024
Learn how scientists at St. Jude are leading research to improve CAR T-cell therapy for osteosarcoma by enhancing chemokine homing.
-
Serotonin uptake regulates ependymoma tumor growth
07/31/2024
Discover how St. Jude Children’s Research Hospital and Baylor College of Medicine found serotonin's role in ependymoma tumor growth, opening new drug possibilities.
-
St. Jude gene panel for pediatric cancers increases access to high-quality testing
07/26/2024
Discover how a gene panel for pediatric cancer concentrates the pediatric cancer genome project & high-end sequencing’s findings into a single practical test.
-
St. Jude Children’s Research Hospital earns DNV accreditation
07/23/2024
Collaboration between St. Jude and DNV will strengthen the institution’s processes and improve patient care.
-
Lab-grown human neuron assembloids effectively model synaptic plasticity
07/18/2024
See how St. Jude scientists model the human thalamocortical neural network using lab-grown cells, revealing synaptic communication and demonstrating plasticity.
-
Biomolecular condensate ‘molecular putty’ properties found encoded in protein sequence
07/02/2024
See how biomolecular condensates like stress granules behave like putty, a viscoelastic material that shares properties of liquids and solids based on the timescale of interactions.
-
Tri Delta Raises Historic $100 Million in Grassroots Fundraising for St. Jude Children’s Research Hospital
07/01/2024
Tri Delta has raised $100 million for St. Jude in their 25-year partnership, becoming the first Greek organization to reach the historic milestone. Since 1999, Tri Delta collegians and alumnae have raised the funds through small-dollar fundraising efforts.
-
Master autoimmune regulator gets by with a little help from its friends
06/27/2024
See how St. Jude researchers investigated Foxp3 function as a transcription cofactor in regulatory T cells in immune system activation and suppression.
-
Study identifies high-risk type of childhood acute leukemia and potential treatment strategy
06/25/2024
Learn how St. Jude assembled an international cohort to better understand γδ T-ALL, a high-risk form of childhood cancer, and propose a new targeted treatment.
-
Children genetically prone to cancer benefit from early standardized surveillance
06/20/2024
Discover new research that shows cancer surveillance deployed immediately after finding a genetic predisposition leads to earlier tumor detection & treatment.
-
St. Jude scientists solve decades long mystery of NLRC5 sensor function in cell death and disease
06/14/2024
Learn about immunology research from the St. Jude laboratory of Thirumala-Devi Kanneganti, PhD, that revealed the function of the NLRC5 innate immune sensor.
-
Novel insights into fluorescent ‘dark states’ illuminate ways forward for improved imaging
06/14/2024
See how fluorescent dark triplet states in single molecule FRET can be avoided with self-healing fluorophores.
-
Age is just a number: Immune cell ‘epigenetic clock’ ticks independently of organism lifespan
06/12/2024
See how St. Jude researchers use epigenetic clock, DNA methylation and mouse model to demonstrate that T cell proliferation can stretch past organism lifespan and acute lymphoblastic leukemia T cells appear hundreds of years old.
-
ALSAC and Other Local Organizations Collaborate to Provide Students from Memphis-Shelby County Schools with Life Skills Training
05/30/2024
ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital, and Memphis-Shelby County Schools celebrated the graduation of 83 local high school students from the Fervent Family Program at a ceremony held at Dixon Gallery & Gardens.
-
‘Goldilocks’ binding strength determines anti-cancer T-cell efficacy and fate
05/30/2024
Learn how progenitor exhausted T cells’ receptor binding strength to cancer antigens determines the anti-cancer response with implications for immunotherapy.
-
Cell-targeting technology allows researchers to isolate neuronal subpopulations and link them to behavioral states
05/27/2024
See how neurology tool Conditional Viral Expression by Ribozyme Guided Degradation (ConVERGD) allows researchers to isolate subpopulations of cells with increased accuracy and ease
-
Repurposed protease controls important signaling molecule-activating protein
05/22/2024
See how cryo-EM reveals iRhom2 acts as regulator of ADAM17 activity and controls activation of tumor necrosis factor and many growth factors by binding ADAM17 prodomain.
-
Novel inhibitor insights offer pathway to preventing PXR-associated drug resistance
05/14/2024
See how novel pregnane X receptor inhibitors offer structural understanding behind activator and repressor activity, guiding future drug design research to combat drug resistance
-
Domino’s® announces historic goal to raise $300 million to benefit the lifesaving mission of St. Jude Children’s Research Hospital®
05/09/2024
Domino’s®, the largest pizza company in the world, announced the largest corporate or private financial commitment to a children’s hospital: a pledge to bring its fundraising total to $300 million by 2034 to benefit St. Jude.
-
Honoring three dreamers: Entrepreneur, artist, civic leader to receive top accolades at St. Jude Spirit of the Dream
05/07/2024
Community leader A C Wharton, Jr., master potter Peter Woods and trailblazing businesswoman Carolyn Chism Hardy will be honored with the Legacy Award and the St. Jude Spirit of the Dream award.
-
Miami's Philanthropic Community Raises $785,000 for St. Jude Children's Research Hospital at 22nd Annual FedEx/ St. Jude Angels & Stars Gala
05/06/2024
Philanthropists, influencers and celebrities, including Billboard Latin Music award winner Tito Nieves, Emmy® award-winning journalist Jackie Nespral and host, podcaster and author Alberto Sardiñas, raised $785,000 at the 22nd annual FedEx/ St. Jude Angels & Stars Gala.
-
Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets
05/03/2024
St. Jude found 156 potential targets for chimeric antigen receptor (CAR) T–cell immunotherapy. Explore the discovery’s promise to improve cancer therapies.
-
Unraveling the roles of non-coding DNA explains childhood cancer’s resistance to chemotherapy
05/01/2024
Non-coding DNA variants contribute to acute lymphoblastic leukemia (ALL) chemotherapy resistance. Explore new technology used in the St. Jude-led discovery.
-
Hongbo Chi, PhD named 2023 AAAS Fellow
04/29/2024
The St. Jude immunologist has made valuable contributions to immunometabolism. AAAS is the world’s largest general scientific society.
-
Targeting specific protein regions offers a new treatment approach in medulloblastoma
04/25/2024
Explore how research targeting EP300/CBP protein in Group 3 medulloblastoma may advance targeted pediatric brain tumor treatments by inhibiting bromodomains.
-
Uforia unites artists, communities nationwide to support St. Jude Children’s Research Hospital this Dia del Niño
04/25/2024
Musical artists Ana Bárbara and DannyLux will join the Uforia Audio Network to celebrate Dia del Niño by rallying audiences behind the lifesaving mission of St. Jude, asking audiences to become monthly donors known as Ángeles de Esperanza (Angels of Hope).
-
Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors
04/23/2024
Learn how ancestry changes genetic risk variants’ impact on type 2 diabetes in childhood cancer survivors & alkylating agent exposure magnifies diabetes risk.
-
"Run Rich Run" celebrates 20 years: 20th run benefiting St. Jude Children’s Research Hospital to air during NFL Network’s 2024 NFL Draft coverage
04/22/2024
Run Rich Run, the charitable campaign to raise awareness and support for St. Jude Children’s Research Hospital, celebrates its 20th year with Rich Eisen's run airing during the NFL Network's 2024 NFL Draft coverage.
-
Metabolic health before vaccination determines effectiveness of anti-flu response
04/18/2024
Poor metabolic health or dysfunction, not obesity, leads to poor anti-influenza immune responses. Learn about the new St. Jude influenza vaccination research.
-
Andrew Smith, MD, PhD, named chair of Diagnostic Imaging at St. Jude Children’s Research Hospital
04/15/2024
Andrew Smith, MD, PhD, named chair of Diagnostic Imaging at St. Jude Children's Research Hospital. Smith is an expert in the use of artificial intelligence in imaging and medicine.
-
New drug prevents flu-related inflammation and lung damage
04/10/2024
New RIPK3 inhibitor UH15-38 protected models against influenza-induced inflammation and lung injury. Learn how it selectively blocks pathogenic necroptosis.
-
St. Jude survivorship portal brings researchers ‘one-click’ away from discovery
04/09/2024
Learn about the survivorship portal, a part of the St. Jude Cloud ecosystem, and find out how researchers can use the portal to make new discoveries.
-
Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
04/08/2024
Discover how a vulnerability in treatment resistant B-cell acute lymphoblastic leukemia (B-ALL) was uncovered by single-cell analysis of developmental stage.
-
Renowned St. Jude clinician and researcher to receive coveted award at AACR annual meeting
04/04/2024
St. Jude researchers to present their science at AACR annual meeting.
-
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
03/28/2024
See how chemotherapy resistance in bilateral Wilms tumor implies stromal predominant with favorable outcomes if surgery follows rather than further chemo or biopsy
-
Researchers turn back the clock on cancer cells to offer new treatment paradigm
03/27/2024
Rhabdoid tumor cells were reverted from a cancerous state to normal. Discover how deletion of quality control protein DCAF5 may treat an undruggable cancer.
-
Rasheeda S. Liberty Appointed as first Black woman to serve on ALSAC Professional Advisory Board
03/25/2024
Leader and philanthropist Rasheeda S. Liberty has been appointed to serve on the ALSAC Professional Advisory Board, marking a milestone as the first Black woman to hold this prestigious position.
-
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer
03/19/2024
Explore how a T-cell receptor targeting an oncogenic fusion holds treatment promise in fibrolamellar carcinoma (FLC), a rare liver cancer with poor prognosis.
-
Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma
03/19/2024
See how mesenchymal to adrenergic cell change mechanism in MYCN-linked neuroblastoma linked to high MYCN levels, driven by KDM4 induction.
-
Scientists find core regulatory circuit controlling identity of aggressive leukemia
03/19/2024
Anaplastic large cell lymphoma is an aggressive form of cancer. Learn how a core regulatory circuit & STAT3 in ALCL may lead to new therapeutic opportunities.
-
Role in mitochondrial metabolism paints more complete picture of MCL-1 function
03/18/2024
See how anti-apoptosis oncoprotein MCL-1 also functions in fatty acid metabolism by binding ACSL1 explaining cardiac toxicity in clinical trials
-
Urban One’s inspirational stations raise $1.5 Million for St. Jude Children’s Research Hospital
03/12/2024
Radio One and Reach Media, the audio divisions of Urban One, Inc., joined forces with St. Jude to raise $1,553,247 nationally during the 17th annual St. Jude Children’s Research Hospital® Radiothon on Feb. 29 and March 1.
-
Kappa Alpha Psi Fraternity, Inc. announces new $2 million fundraising commitment for St. Jude Children’s Research Hospital
03/11/2024
Artist Derek Fordjour and Grizzlies head coach Lionel Hollins were honored for their pioneering work and philanthropy with the Spirit of the Dream Award.
-
Rare inflammatory disease responds best to double inhibition
03/06/2024
Ruxolitinib treats hemophagocytic lymphohistiocytosis (HLH) models better than JAK1 or 2 single inhibitors. Discover its promise in an ongoing clinical trial.
-
St. Jude Children’s Research Hospital/ALSAC Rings The Nasdaq Stock Market Opening Bell on Leap Day
02/29/2024
This Leap Day, St. Jude Children’s Research Hospital® rang the Opening Bell at The Nasdaq MarketSite in Times Square. The ceremony kicked off the St. Jude Leap Day Challenge, a campaign that invites supporters to leap into saving more lives.
-
St. Jude taps health care start-up veteran as first Senior Vice President of Tech Commercialization
02/20/2024
New VP will work with St. Jude researchers to commercialize discoveries made at St. Jude to benefit more patients.
-
Legends for Charity Honors Tony Romo With 2024 Pat Summerall Award, Annual Dinner Raises Record $2.1M for St. Jude Children's Research Hospital®
02/14/2024
The 19th annual Legends for Charity® dinner hosted top names in sports broadcasting during Super Bowl LVIII week to present Tony Romo, Lead Analyst for THE NFL ON CBS, with the coveted Pat Summerall Award.
-
Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia
02/12/2024
Learn why bispecific chimeric antigen receptor (CAR) T-cell therapy for acute myeloid leukemia (AML) improved treatment, confirmed by artificial intelligence.
-
St. Jude Children’s Research Hospital and TelevisaUnivision score big with first Spanish language charity spot for St. Jude to air during Sunday’s big game
02/08/2024
Thanks to a partnership between St. Jude and TelevisaUnivision, viewers will get a glimpse of the confetti that streams at one of the most joyous moments for St. Jude families in Univision's first charity advertising spot during Sunday’s big game.
-
Sara Federico, MD, named director of the Solid Tumor Division at St. Jude Children’s Research Hospital
02/07/2024
Established clinician researcher will focus on novel treatments and clinical trials for difficult-to-treat childhood cancers.
-
Inaugural class of Damon Runyon– St. Jude Pediatric Cancer Research Fellows announced
02/01/2024
This initiative supports early-career scientists studying pediatric cancer, addressing a funding gap between pediatric and adult cancer research.
-
St. Jude Children’s Research Hospital adds $13 million project to Research Collaboratives Program
01/18/2024
Created as part of the 2022-2027 Strategic Plan, the St. Jude Research Collaboratives program is part of an overall effort by the institution to fund collaborative research addressing complex scientific problems with transformative potential for the diseases treated at St. Jude.
-
Molecular ‘super-glue’ shows promise of cancer drug discovery platform
01/16/2024
Learn how St. Jude created a molecular super-glue to target cancer-related protein casein kinase 1 alpha (CK1α) & how the platform may lead to new treatments.
-
St. Jude Home Care, LLC is first U.S. pediatric home health agency to earn new category of industry certification
01/16/2024
The mobile service was certified by CHAP in pediatrics and home health.
-
HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia
01/12/2024
See how St. Jude researchers use CRISPR-Cas9 to identify RBM5 as a key play in HOXA9-associated leukemia and how RBM5 was shown to have a duel function as splicing factor and transcription factor.
-
Two common biomarkers predict heart risk in asymptomatic childhood cancer survivors
01/11/2024
Find how global longitudinal strain (GLS) & N-terminal-pro-B-type natriuretic peptide (NT-proBNP) improved heart risk predictions in pediatric cancer survivors.
-
Updated genomic landscape for pediatric acute myeloid leukemia enables new treatment possibilities
01/11/2024
Scientists at St. Jude Children’s Research Hospital refined and enhanced the classification system for a type of pediatric leukemia using genomic and transcriptomic analysis.
-
Acute pediatric critical illness definition enables global research
01/08/2024
Find how a new more inclusive consensus definition of acute pediatric critical illness will fuel research across the globe due to St. Jude-led collaboration.
